Ironwood Pharmaceuticals Inc (IRWD)
3.44
+0.10
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
3.42
-0.02
(-0.58%)
After-Hours: 20:00
Ironwood Pharmaceuticals Max Drawdown (5Y): 74.56% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 74.56% |
| September 30, 2024 | 74.56% |
| August 31, 2024 | 73.79% |
| July 31, 2024 | 63.88% |
| June 30, 2024 | 63.88% |
| May 31, 2024 | 61.94% |
| April 30, 2024 | 60.99% |
| March 31, 2024 | 60.99% |
| February 29, 2024 | 60.99% |
| January 31, 2024 | 60.99% |
| December 31, 2023 | 60.99% |
| November 30, 2023 | 60.99% |
| October 31, 2023 | 60.99% |
| September 30, 2023 | 60.99% |
| August 31, 2023 | 60.99% |
| July 31, 2023 | 60.99% |
| June 30, 2023 | 60.99% |
| May 31, 2023 | 60.99% |
| April 30, 2023 | 60.99% |
| March 31, 2023 | 60.99% |
| February 28, 2023 | 60.99% |
| January 31, 2023 | 60.99% |
| December 31, 2022 | 60.99% |
| November 30, 2022 | 60.99% |
| October 31, 2022 | 60.99% |
| Date | Value |
|---|---|
| September 30, 2022 | 60.99% |
| August 31, 2022 | 60.99% |
| July 31, 2022 | 60.99% |
| June 30, 2022 | 60.99% |
| May 31, 2022 | 60.99% |
| April 30, 2022 | 60.99% |
| March 31, 2022 | 60.99% |
| February 28, 2022 | 60.99% |
| January 31, 2022 | 60.99% |
| December 31, 2021 | 60.99% |
| November 30, 2021 | 60.99% |
| October 31, 2021 | 60.99% |
| September 30, 2021 | 60.99% |
| August 31, 2021 | 60.99% |
| July 31, 2021 | 60.99% |
| June 30, 2021 | 60.99% |
| May 31, 2021 | 60.99% |
| April 30, 2021 | 60.99% |
| March 31, 2021 | 60.99% |
| February 28, 2021 | 60.99% |
| January 31, 2021 | 60.99% |
| December 31, 2020 | 60.99% |
| November 30, 2020 | 60.99% |
| October 31, 2020 | 60.99% |
| September 30, 2020 | 60.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
60.99%
Minimum
Nov 2019
74.56%
Maximum
Sep 2024
61.77%
Average
60.99%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -25.51 |
| Beta (5Y) | 0.4745 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 39.57% |
| Historical Sharpe Ratio (5Y) | -0.4899 |
| Historical Sortino (5Y) | -0.6458 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.65% |